Interstitial Lung Disease
Interstitial lung disease is a classification covering more than 200 types of lung disorders, all of which affect the interstitium, or the area surrounding the air sacs. Most of the disorders cause a thickening of the interstitium, generally resulting from excess mucous, inflammation, and scarring. The progressive scarring of lung tissue eventually interferes with the ability to breathe by reducing the intake of oxygen. Some of the disorders also may affect blood vessels, airways to the lungs, the outside lining of the lungs (called the pleura), and even the air sacs themselves. A wide range of causes are associated with these lung disorders, including bacteria, smoking, asbestos, and autoimmune conditions such as rheumatoid arthritis.
UAB interventional pulmonologists and thoracic surgeons collaborate in treating lung cancer with less invasive procedures.
Medical Minute: Pulmonary & Thoracic Surgery
Hitesh Batra, MD, and Benjamin Wei, MD, discuss the collaborative relationship between UAB Medicine's interventional pulmonologists and thoracic surgeons and how less invasive treatments for lung nodules and lung cancer lead to faster recovery times.
UAB is an active participant in research and clinical trials for interstitial lung disease. We encourage you to speak to your physician about research and clinical trial options and browse the link below for more information.View Clinical Trials
Pandemic Response Helps UAB Earn No. 1 Spot on Forbes List of Best Large Employers
From Medellín to Medicine: Optometrist Marcela Frazier Built a Practice that Honors Her Heritage
Callahan Trussville Q&A
Women's COVID-19 Information including Vaccination of Pregnant or Lactating Women
When can you expect the worst of COVID-19 symptoms after you test positive?